Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo.
about
Role of EPAC in cAMP-Mediated Actions in Adrenocortical CellsExchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: Structure, function and therapeuticsBiochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 "therapeutic window".The pleiotropic role of exchange protein directly activated by cAMP 1 (EPAC1) in cancer: implications for therapeutic intervention.Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists.Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors.Identification of Extracellular Segments by Mass Spectrometry Improves Topology Prediction of Transmembrane Proteins.Epac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance.Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling.EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets.Epac1 links prostaglandin E2 to β-catenin-dependent transcription during epithelial-to-mesenchymal transition.A cell-based, quantitative and isoform-specific assay for exchange proteins directly activated by cAMP.An Orally Active Epac Inhibitor Reverses Mechanical Allodynia and Loss of Intraepidermal Nerve Fibers \iIn A Mouse Model of Chemotherapy-Induced Peripheral Neuropathy.Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists.Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.
P2860
Q26744605-9D693297-86FA-4D13-BEF5-730D70FD8F5AQ28608179-647421D2-A1F6-495D-9989-CE12EF291E33Q34467944-E5F47C90-024A-4466-8DC0-3DAF17E86418Q36398745-8167886B-CB2D-4F85-8552-D0CFC852ED02Q36624204-150C0D39-ACEB-4612-B23B-B9AAFC1C3117Q36902839-1E2D308F-B24C-4395-95EF-1F1326CFABF5Q37638014-B5CB1D6F-F532-4281-98E5-54BCDEF2E61DQ37642259-E4276C9A-9335-4232-828E-35A554F060C3Q37708984-BA7163D8-B080-49F9-9E16-F99302E0BFCBQ37722152-382F7A6F-F226-497B-A17B-DBB9E4361DFDQ38747476-FE35E2BB-BD13-493A-8C4B-FC67C8A46AADQ40854700-6068B225-D926-4ACA-B5B5-4780920BA089Q41108182-AA4E0903-94F1-4DCF-92D3-F3D5A1660E52Q47549123-366400A8-F301-44E1-8540-5AFF78262761Q51063407-6E82263F-66B8-4976-A7BF-8EF4777B6FF0Q52656382-F0290E4B-25FC-4CBF-BFFA-5A1C2AA8FAAB
P2860
Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@ast
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@en
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@nl
type
label
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@ast
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@en
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@nl
prefLabel
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@ast
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@en
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@nl
P2093
P2860
P356
P1476
Pharmacological inhibition and ...... tic cancer metastasis in vivo.
@en
P2093
Celia Chao
Fang C Mei
Igor Patrikeev
Mark R Hellmich
Massoud Motamedi
Muayad Almahariq
Xiaodong Cheng
P2860
P304
P356
10.1124/MOL.114.095158
P577
2014-11-10T00:00:00Z